JP2006519807A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519807A5
JP2006519807A5 JP2006504625A JP2006504625A JP2006519807A5 JP 2006519807 A5 JP2006519807 A5 JP 2006519807A5 JP 2006504625 A JP2006504625 A JP 2006504625A JP 2006504625 A JP2006504625 A JP 2006504625A JP 2006519807 A5 JP2006519807 A5 JP 2006519807A5
Authority
JP
Japan
Prior art keywords
formula
compound
compounds
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006504625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006519807A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/002460 external-priority patent/WO2004080464A1/en
Publication of JP2006519807A publication Critical patent/JP2006519807A/ja
Publication of JP2006519807A5 publication Critical patent/JP2006519807A5/ja
Pending legal-status Critical Current

Links

JP2006504625A 2003-03-11 2004-03-10 癌およびmapキナーゼ関連疾患の処置のためのイソキノリン誘導体の使用 Pending JP2006519807A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45362403P 2003-03-11 2003-03-11
PCT/EP2004/002460 WO2004080464A1 (en) 2003-03-11 2004-03-10 Use of isoquinoline derivatives for treating cancer and map kinase related diseases

Publications (2)

Publication Number Publication Date
JP2006519807A JP2006519807A (ja) 2006-08-31
JP2006519807A5 true JP2006519807A5 (https=) 2007-04-26

Family

ID=32990797

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006504625A Pending JP2006519807A (ja) 2003-03-11 2004-03-10 癌およびmapキナーゼ関連疾患の処置のためのイソキノリン誘導体の使用

Country Status (22)

Country Link
EP (1) EP1603566B1 (https=)
JP (1) JP2006519807A (https=)
KR (1) KR20050108383A (https=)
CN (1) CN1758910A (https=)
AT (1) ATE421324T1 (https=)
AU (1) AU2004218914A1 (https=)
BR (1) BRPI0408257A (https=)
CA (1) CA2518530A1 (https=)
DE (1) DE602004019193D1 (https=)
ES (1) ES2318276T3 (https=)
HR (1) HRP20050788A2 (https=)
IS (1) IS8064A (https=)
MA (1) MA27724A1 (https=)
MX (1) MXPA05009687A (https=)
NO (1) NO20054647L (https=)
PL (1) PL1603566T3 (https=)
PT (1) PT1603566E (https=)
RU (1) RU2325159C2 (https=)
TN (1) TNSN05223A1 (https=)
TW (1) TW200501955A (https=)
WO (1) WO2004080464A1 (https=)
ZA (1) ZA200506571B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05012377A (es) 2003-05-15 2006-05-25 Arqule Inc Derivados de imidazotiazoles e imidazoxazol como inhibidores de p38.
AR045944A1 (es) * 2003-09-24 2005-11-16 Novartis Ag Derivados de isoquinolina 1.4-disustituidas
WO2006010082A1 (en) 2004-07-08 2006-01-26 Arqule, Inc. 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
JP2008517064A (ja) 2004-10-19 2008-05-22 アークル インコーポレイテッド P38mapキナーゼのイミダゾオキサゾールおよびイミダゾチアゾール阻害剤の合成
CN101160131A (zh) * 2005-02-25 2008-04-09 诺瓦提斯公司 Bcr-abl和raf抑制剂的药物组合产品
JP5049970B2 (ja) * 2005-07-26 2012-10-17 サノフイ Rho−キナーゼ阻害剤としてのシクロヘキシルアミンイソキノロン誘導体
US8318941B2 (en) 2006-07-06 2012-11-27 Bristol-Myers Squibb Company Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
CA2639416C (en) * 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
EP3284494A1 (en) 2009-07-30 2018-02-21 Tandem Diabetes Care, Inc. Portable infusion pump system
CN103038364A (zh) 2010-03-09 2013-04-10 达纳-法伯癌症研究所公司 诊断和治疗具有或发展对于第一种癌症治疗的抗性的患者中的癌症的方法
US9056855B2 (en) * 2010-10-28 2015-06-16 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN103435430B (zh) * 2013-08-08 2015-02-18 四川大学 一种还原酰胺类化合物的方法
KR102119943B1 (ko) 2018-05-23 2020-06-05 주식회사 포스코 시편배치유닛 및 이를 포함하는 도장밀착성 실험장치
US20210275516A1 (en) * 2018-07-02 2021-09-09 Ecole Polytechnique Federale De Lausanne (Epfl) Lactate enhancing compounds and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
ATE459616T1 (de) * 1998-08-11 2010-03-15 Novartis Ag Isochinoline derivate mit angiogenesis-hemmender wirkung
GT200000158A (es) * 1999-09-28 2002-03-16 Piridinas y piridacinas sustituidas con actividad de inhibicion de angiogenesis.
PT1254138E (pt) * 2000-02-09 2005-09-30 Novartis Ag Derivados de piridina que inibem a angiogenese e/ou o receptor de tirosina cinase do vegf
US20030078271A1 (en) * 2001-01-31 2003-04-24 Blackburn Thomas P. Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
DE60239097D1 (de) * 2001-03-02 2011-03-17 Gpc Biotech Ag Drei-hybrid-assaysystem
MXPA04005561A (es) * 2001-12-21 2004-12-06 Bayer Pharmaceuticals Corp Terapias de combinacion anti-angiogenesis que comprenden derivados de piridazina o piridina.
US7220775B2 (en) * 2002-08-07 2007-05-22 H. Lundbeck A/S Compound useful for the treatment of neuropathic pain

Similar Documents

Publication Publication Date Title
JP2006519807A5 (https=)
AU2001252272B2 (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
KR102303011B1 (ko) 1,3,5-트라이아진 유도체 및 이의 사용 방법
CN112239469A (zh) 靶向蛋白降解c-Met降解剂及其制备方法与应用
JP2006502119A5 (https=)
JP2015509098A5 (https=)
JP2016525075A5 (https=)
CA1320204C (en) Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters
JP2018520109A (ja) ピリド−アザヘテロサイクリック化合物及びその製造方法と用途
JP2005516969A (ja) メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピロールモジュレーター
WO2004002963A1 (ja) アミド誘導体及び医薬
JP2006508979A5 (https=)
KR20120076350A (ko) 키나아제 억제제, 이의 전구약물 형태 및 이들의 치료 용도
JP2010505861A5 (https=)
JP2003513066A5 (https=)
JP2019533007A5 (https=)
JP2005504790A5 (https=)
JP2003512471A5 (https=)
KR960007594A (ko) 2,3- 다리걸친 1,4-디히드로피리딘, 그의 제조 방법 및 그의 약제로서의 용도
JP2011515441A5 (https=)
PT98607A (pt) Processo para a preparacao de derivados de quinolina
JP2020517745A5 (https=)
KR20150079677A (ko) 디아실글리세롤 아실트랜스퍼라제 억제제로서의 신규 화합물
JP2007529471A5 (https=)
PT1446381E (pt) Amidas do ácido antranílico e a sua utilização farmacêutica